Further information on the first study:
[Note: I think the first study references the second study.]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797060/
"The patients in the metformin interruption group were younger, had a higher level of glycated hemoglobin (HbA1c), increased use of anti-diabetic drugs including α-glucosidase inhibitors, dipeptidyl peptidase-4 (DDP-4) inhibitors and insulin, and increased use of statins compared to those in the metformin continuation group"
So a level playing field then. Statistics speaker needed to decide if the differences are significant.
My statistical knowledge isn't good enough to interpret all the probabilities, perhaps someone else can comment?
It does, however, say:
"In this retrospective cohort study, the patients with type 2 DM who received metformin therapy for at least 6 months had a greater decline in eGFR if they continued metformin therapy compared to those who discontinued metformin treatment for at least 100 days. The continuation of metformin therapy was significantly associated with a decline in renal function in the patients with DM and moderate CKD. Other risk factors for a decline in renal function included high serum LDL-C, high HbA1c, low baseline eGFR, high uric acid level, high UACR, and the use of ACEIs and/or ARBs."
From the pretty pictures it looks as though eGFR improved in those off Metformin for 100 days, but got worse in the ones still on Metformin. The implication from this is that Metformin is associated a deleterious effect on eGFR but the patients in the trial were on such a cocktail of drugs that I'm not sure how this relates to someone with reasonable control and just Metformin.
Also:
"A previous clinical study demonstrated that metformin users with a renal function of eGFR <60 mL/min/1.73 m2 had a higher risk of lactic acidosis or elevated lactate concentrations [
16]. Metformin-associated lactic acidosis can cause metabolic acidosis in patients with moderate CKD, and this has been shown to have a deleterious effect on renal function leading to a decline in eGFR and progression of CKD [
17–
19]. Several factors have been associated with the effect of metabolic acidosis on the decline in renal function, including ammonia-induced complement activation and acidosis-induced increased production of endothelin and aldosterone [
19]. Taken together, all of these factors can cause tubule-interstitial injury and mediate a decline in eGFR [
19], which may explain the inconsistent findings with regards to the effect of metformin on renal function."
So (I think) more lactate in the blood and more acid blood may explain the kidney damage.
"Diabetic nephropathy is associated with oxidative stress caused by a persistent hyperglycemic state and increase in advanced glycation end products [
20]."
Which then raises the question "Is higher BG due to not taking Metformin more of a risk to the kidneys than a lower BG and taking Metformin?".
It does say:
"
In conclusion, continuous metformin treatment in patients with DM and moderate CKD was associated with a worsening in renal function. Metformin is currently indicated for diabetic patients with eGFR > 30 ml/min/1.73 m2. However, according to the findings of the present study, metformin should be prescribed with caution for patients with DM and moderate CKD, and renal function should be followed closely in these patients."
O.K. - losing the will to live here.
I think I have seen that in the cohort of patients in the first study eGFR worsened over the trial period for those on Metformin and improved for those not on Metformin but the improvement was not as fast as the worsening. In other words you would have to spend more time off Metformin than on to maintain a steady eGFR (all other things being equal).
As I said above, it is not clear if the risks of running a higher BG are worse than using Metformin when you have moderate chronic CKD.
- Stage 3A Moderate CKD (GFR = 45-59 mL/min)
- Stage 3B Moderate CKD (GFR = 30-44 mL/min)
So not really that much wiser apart from there being at least one study where there has been a noted difference in the progress of CKD when using Metformin. Although I haven't managed to interpret how fast the deterioration is.
Bootnote: my eGFR has been up and down like a roller blind over the years and I have been on Metformin for a number of years, so this may not be the whole story.